(1R,4S)-2-Azabicyclo[2.2.1]heptane hydrochloride, 97%, 500mg

8-(2-Chloro-6-fluorophenyl)-8-oxooctanoic acid, 97.0%, 1g

trans-2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)styrene, 95.0%, 5g

h-dapa-oh.hbr, 95.0%, 5g

(2Z)-but-2-enedioic acid; 3-ethyl 5-methyl 2-[(2-aminoethoxy)methylidene]-4-(2-chlorophenyl)-6-methyl-1,2,3,4-tetrahydropyridine-3,5-dicarboxylate, 95%, 5g

DIMETHYL 2-ETHYLMALONATE, 95.0%, 500g

Soporte para cubetas ROTILABO®, 5 pieza(s)

2-desoxi-D-glucosa, mínimo 98 %, para bioquímica, 50 mg, envase de vidrio

(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 96%, 1g

N-Hydroxypicolinimidoyl chloride, 95.0%, 1g

Tazarotenic acid, 99.57%, 250mg

methyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate hydrochloride, 95.0%, 100mg